Suchergebnisse - "Garassino, Marina"

PubPharm (38)

1

Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell Lung Cancer With Novel Driver Alterations

enthalten in: Clinical lung cancer | 2023

von Brambilla, M. | Beninato, T. | Piemontese, A. | +24

2

Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer : 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Garassino, M. | Gadgeel, S. | Speranza, G. | +18

3

Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC : The BEVERLY Multicenter Randomized Phase 3 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Piccirillo, M. | Bonanno, L. | Garassino, M. | +30

4

Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors : Focus on novel therapies

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2022

von Johnson, M. | Garassino, M. | Mok, T. | +1

5

Adenosine Pathway in NSCLC With Molecular Drivers : Can Oncogene Addiction Translate Into Immune Addiction?

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Ferrara, R. | Milani, M. | Garassino, M. | +2

CommentOn: J Thorac Oncol. 2021 Apr;16(4):583-600. - PMID 33388477

6

Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies : ZENITH20-2 Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Le, X. | Cornelissen, R. | Garassino, M. | +8

CommentIn: J Clin Oncol. 2022 Mar 1;40(7):693-697. - PMID 35072488

7

Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Popat, S. | Brustugun, O. | Cadranel, J. | +9

8

Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC : Results from the expanded access program

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Prelaj, A. | Bottiglieri, A. | Proto, C. | +19

CommentIn: Eur J Cancer. 2021 May;149:233-234. - PMID 33824058

9

First Case Report of Pregnancy on Alectinib in a Woman With Metastatic ALK-Rearranged Lung Cancer : A Case Report

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Scarfone, G. | Fumagalli, M. | Imbimbo, M. | +11

10

Uncommon targets in non-small cell lung cancer : Everyone wants a slice of cake

enthalten in: Critical reviews in oncology/hematology | 2021

von De Toma, A. | Lo Russo, G. | Signorelli, D. | +10